BioMarin Pharmaceutical Inc. - Strategy, SWOT, and Corporate Finance Report

Datamonitor, June 2011, Pages: 62

The BioMarin Pharmaceutical Inc.’s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Scope:

- Provides detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- Offers an in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Contains five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for BioMarin Pharmaceutical Inc.
- Provides intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- Captures the latest news about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Includes large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

This report includes BioMarin Pharmaceutical Inc.'s business description, segment overview, company history, products and services, SWOT analysis, 5-year financial statements and ratios, management statement, key executives and biographies, key competitors, locations and subsidiaries, contact information, latest news, and corporate activity including M&A, private equity, venture financing, public offerings, private placements and partnerships, and a list of legal and financial advisors.

Reasons to Purchase:

- Gain understanding of the company and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess prospective partners, vendors and suppliers
- Support sales activities by understanding your customers' businesses better
- Stay up to date on your competitors' business structure, strategy and prospects

Company Snapshot
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Financial Analysis
BioMarin Pharmaceutical Inc.: Financial Overview
BioMarin Pharmaceutical Inc.: Five Year Company Financials
BioMarin Pharmaceutical Inc.: Key Income Statement Data
BioMarin Pharmaceutical Inc.: Key Balance Sheet Data
BioMarin Pharmaceutical Inc.: Key Cash Flow Data
BioMarin Pharmaceutical Inc.: Key Market Data
BioMarin Pharmaceutical Inc.: Valuation Ratios
BioMarin Pharmaceutical Inc.: Profitability Ratios
BioMarin Pharmaceutical Inc.: Management Efficiency Ratios
BioMarin Pharmaceutical Inc.: Financial Strength Ratios
BioMarin Pharmaceutical Inc.: Operational Efficiency Ratios
BioMarin Pharmaceutical Inc.: Others
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2007 -YTD-
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
BioMarin Pharmaceutical Inc.: Corporate Venturing
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Contracts
BioMarin Pharmaceutical Inc.: Corporate Governance
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Key Income Statement Data
Table 6: BioMarin Pharmaceutical Inc.: Key Balance Sheet Data
Table 7: BioMarin Pharmaceutical Inc.: Key Cash Flow Data
Table 8: BioMarin Pharmaceutical Inc.: Key Market Data
Table 9: BioMarin Pharmaceutical Inc.: Key Growth Ratios
Table 10: BioMarin Pharmaceutical Inc.: Valuation Ratios
Table 11: BioMarin Pharmaceutical Inc.: Profitability Ratios
Table 12: BioMarin Pharmaceutical Inc.: Management Efficiency Ratios
Table 13: BioMarin Pharmaceutical Inc.: Financial Strength Ratios
Table 14: BioMarin Pharmaceutical Inc.: Operational Efficiency Ratios
Table 15: BioMarin Pharmaceutical Inc.: Others
Table 16: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM)
Table 17: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM)
Table 18: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Table 19: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 20: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 21: BioMarin Pharmaceutical Inc.: Top Deals 2007 -YTD-
Table 22: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 23: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2007 - YTD-2011)
Table 24: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2007 - YTD-2011)
Table 25: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2007 - YTD-2011)
Table 26: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2007 - YTD-2011)
Table 27: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2007 - YTD-2011)
Table 28: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2007 - YTD-2011)
Table 29: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 30: BioMarin Pharmaceutical Inc.: Contracts
Table 31: BioMarin Pharmaceutical Inc.: Corporate Governance
Table 32: BioMarin Pharmaceutical Inc.: Financial Deals
Table 33: BioMarin Pharmaceutical Inc.: Financial Performance
Table 34: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
Table 35: BioMarin Pharmaceutical Inc.: Research & Development
Table 36: BioMarin Pharmaceutical Inc.: Strategy and Operations

List of Figures

Figure 1: BioMarin Pharmaceutical Inc.: Revenue to Net Income (2005-2009)
Figure 2: BioMarin Pharmaceutical Inc.: Revenue/Employee to Net Income/Employee (2005-2009)
Figure 3: BioMarin Pharmaceutical Inc.: Current Assets to Current Liabilities (2005-2009)
Figure 4: BioMarin Pharmaceutical Inc.: Assets, Liabilities to Total Equity (2005-2009)
Figure 5: BioMarin Pharmaceutical Inc.: Free Cash Flow to Cash from Operating Activities (2005-2009)
Figure 6: BioMarin Pharmaceutical Inc.: Net Change in Cash (2005-2009)
Figure 7: BioMarin Pharmaceutical Inc.: Market Capitalization to Year-end Share Price (2005-2009)
Figure 8: BioMarin Pharmaceutical Inc.: Enterprise Value (2005-2009)
Figure 9: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM)
Figure 10: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM)
Figure 11: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2007 - YTD-2011)
Figure 12: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Figure 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2007 - YTD-2011)
Figure 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2007 - YTD-2011)
Figure 15: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2007 - YTD-2011)
Figure 16: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2007 - YTD-2011)
Figure 17: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2007 - YTD-2011)
Figure 18: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2007 - YTD-2011)

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Sports and Fitness Nutrition - Global Strategic Business Report
• Charter Schools - Global Outlook
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Distance Learning - Global Outlook